For us, lead optimization is much more than optimizing potency and selectivity, it's about turning hits into future medicines.
Our goal is to put overwhelming effort into our lead optimization projects so that our partners can enter their compounds into development with confidence. To accomplish this, we first understood why candidates fail in pre-clinical and clinical development and then found ways to assay for many of these failures earlier on. Now we include this "developability" strategy into our Multi-Parametric Lead Optimization efforts using a parallel process approach.
The result: better candidates in less time.
